Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)

By L. Kennedy. 2008

596 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Standards of Medical Care in Diabetes—2008 (2008, background): “A recent study demonstrated the safety and efficacy of using basal-bolus insulin therapy utilizing weight-based dosing in insulin-naı̈ve hospitalized patients with type 2 diabetes (301).”
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control (2009, background): “In most clinical situations, safe and reasonable glycemic control can be achieved with appropriate use of insulin, adjusted according to results of bedside glucose monitoring (102,106,109).”
Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. (2012, background): “The safety of scheduled basal bolus insulin in patients with either newly recognized hyperglycemia or type 2 diabetes has been demonstrated in several studies of noncritically ill hospitalized patients (33, 35, 69, 74).”
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) (2011, result): “We recently reported the results of the RABBIT 2 medicine trial, a prospective multicenter trial comparing the efficacy and safety of a basal-bolus insulin regimen with glargine and glulisine insulin and SSI in insulin-naïve patients with type 2 diabetes mellitus admitted to general medicine wards (”